ResearcherQueen Mary University of LondonNo recent work listed
Kairbaan Hodivala‐Dilke
Matched on ORCID iD 0000-0002-2859-749X; OpenAlex author ID A5008214735. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 3
- Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment. Last author DOI 10.1158/0008-5472.can-20-3807↗
- Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Co-author DOI 10.1016/j.jcmgh.2021.06.023↗
- Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.05.393↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marina Roy-Luzarraga · 2 shared papers, 2021–2022 · strength 0.24
- Paper Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. DOI 10.1016/j.jcmgh.2021.06.023↗
- Paper Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Tr… DOI 10.1158/0008-5472.can-20-3807↗
- Francesca Romana Delvecchio · 2 shared papers, 2016–2021 · strength 0.19
- Hemant Mahendrakumar Kocher · 2 shared papers, 2016–2021 · strength 0.19
- Melania Capasso · 1 shared paper, 2021 · strength 0.12
- Sarah Spear · 1 shared paper, 2021 · strength 0.12
- Rachel Elizabeth Ann Fincham · 1 shared paper, 2021 · strength 0.12
- Victoria Sanz‐Moreno · 1 shared paper, 2022 · strength 0.12
- Ping‐Pui Wong · 1 shared paper, 2022 · strength 0.12
- Frances M. Richards · 1 shared paper, 2022 · strength 0.12
- Dieter Saur · 1 shared paper, 2022 · strength 0.12
- Prabhu Arumugam · 1 shared paper, 2016 · strength 0.07
- Francesco Di Maggio · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.